RxDoctor Payments Data

Cynthia Evans, APRN

Nurse Practitioner · Spring Hill, TNNPI 1750965240

Payments from drug & device makers

$890in general payments, 2019–2025

Across 55 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braeburn Inc.$421
  • Indivior Inc.$224
  • AbbVie$110
  • Gilead$47
  • USWM, LLC$42
  • Boston Scientific$24
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$890100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Braeburn Inc.32$421
Indivior Inc.11$224
AbbVie6$110
Gilead2$47
USWM, LLC2$42
Boston Scientific1$24
Alkermes, Inc.1$23

How this compares

$890 in reported general payments places this provider in the 70th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$52,008
Medicare patients
20
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SublocadeBuprenorphine15$30,695
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl378$28,713
Ibuprofen20$108

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Sublocade$224$30,69515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Spring Hill

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →